Dianthus Therapeutics, Inc. · NASDAQ:DNTH

BCLS Fund III Investments, LP reported a 8.80% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

BCLS Fund III Investments, LP reported a 8.80% stake in Dianthus Therapeutics, Inc., 2,689,707 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
8.80%
Shares
2,689,707
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BCLS Fund III Investments, LP8.80%2,689,707

Source

View original at SEC

Related